Targeting PD-1/PD-L1 interactions for cancer immunotherapy

被引：296
|
作者：
Zitvogel, Laurence [1 ,2 ,3 ,4 ]
Kroemer, Guido [3 ,5 ,6 ,7 ,8 ]
机构：
[1] Inst Gustave Roussy, INSERM, U1015, F-94805 Villejuif, France
[2] Inst Gustave Roussy, Ctr Clin Invest CBT507, Villejuif, France
[3] Inst Gustave Roussy, Villejuif, France
[4] Univ Paris 11, Villejuif, France
[5] INSERM, U848, Villejuif, France
[6] Ctr Rech Cordeliers, Paris, France
[7] Hop Europeen Georges Pompidou, Paris, France
[8] Univ Paris 05, Fac Med, Paris, France
来源：
ONCOIMMUNOLOGY | 2012年 / 1卷 / 08期
关键词：
CELL CARCINOMA PATIENTS; CLINICAL-SIGNIFICANCE; PD-1; PATHWAY; B7-H1; EXPRESSION; MOLECULE; IMMUNOSUPPRESSION; RECEPTORS; LIGAND-1; ANTIBODY;
D O I：
10.4161/onci.21335
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1223 / 1225
页数：3
相关论文
共 50 条
  • [41] Targeting the PD-1/PD-L1 axis in non-small cell lung cancer
    Kumar, Rajiv
    Collins, Dearbhaile
    Dolly, Saoirse
    McDonald, Fiona
    O'Brien, Mary E. R.
    Yap, Timothy A.
    CURRENT PROBLEMS IN CANCER, 2017, 41 (02) : 111 - 124
  • [42] Aptamers Targeting the PD-1/PD-L1 Axis: A Perspective
    Bertrand, Philippe
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (16) : 10878 - 10888
  • [43] Targeting the PD-1/PD-L1 Axis in Human Vitiligo
    Willemsen, Marcella
    Melief, Cornelis J. M.
    Bekkenk, Marcel W.
    Luiten, Rosalie M.
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [44] Advances of biphenyl small-molecule inhibitors targeting PD-1/PD-L1 interaction in cancer immunotherapy
    Chen, Roufen
    Yuan, Dandan
    Ma, JunJie
    FUTURE MEDICINAL CHEMISTRY, 2022, 14 (02) : 97 - 113
  • [45] Immunotherapy Targeting PD-1/PD-L1 in Early-Stage Triple-Negative Breast Cancer
    Yang, Tinglin
    Li, Wenhui
    Huang, Tao
    Zhou, Jun
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (03):
  • [46] PD-L1 in Systemic Immunity: Unraveling Its Contribution to PD-1/PD-L1 Blockade Immunotherapy
    Bocanegra, Ana
    Blanco, Ester
    Fernandez-Hinojal, Gonzalo
    Arasanz, Hugo
    Chocarro, Luisa
    Zuazo, Miren
    Morente, Pilar
    Vera, Ruth
    Escors, David
    Kochan, Grazyna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (16) : 1 - 17
  • [47] Biomarker recommendation for PD-1/PD-L1 immunotherapy development in pediatric cancer based on digital image analysis of PD-L1 and immune cells
    Silva, Manuel A.
    Triltsch, Nicolas
    Leis, Simon
    Kanchev, Ivan
    Tan, Tze Heng
    Van Peel, Benjamine
    Van Kerckhoven, Marian
    Deschoolmeester, Vanessa
    Zimmermann, Johannes
    JOURNAL OF PATHOLOGY CLINICAL RESEARCH, 2020, 6 (02) : 124 - 137
  • [48] PD-1 and PD-L1: architects of immune symphony and immunotherapy breakthroughs in cancer treatment
    Parvez, Adil
    Choudhary, Furqan
    Mudgal, Priyal
    Khan, Rahila
    Qureshi, Kamal A.
    Farooqi, Humaira
    Aspatwar, Ashok
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [49] Emerging role of ubiquitination/ deubiquitination modification of PD-1/PD-L1 in cancer immunotherapy
    Ding, Peng
    Ma, Zhiqiang
    Fan, Yizeng
    Feng, Yingtong
    Shao, Changjian
    Pan, Minghong
    Zhang, Yimeng
    Huang, Di
    Han, Jing
    Hu, Yi
    Yan, Xiaolong
    GENES & DISEASES, 2023, 10 (03) : 848 - 863
  • [50] Recent development in clinical applications of PD-1 and PD-L1 antibodies for cancer immunotherapy
    Liu, Bingshan
    Song, Yongping
    Liu, Delong
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 10
12345